« Back to the previous page

Also available in:

Phase I clinical trials CRO company wanted in Europe

Company to buy

  • Size: mid-sized or large company
  • Revenue: 3-30M EUR
  • Location of the target: Europe
  • Reason for acquisition: The company decided to sell its Phase 2 and Phase 3 capabilities and  is now looking to grow further into phase I CRO activity.  
  • #CFIE PHB038 

Overview of this buyer for Phase I clinical trials CRO 

The buyer is a contract research organization that has a focus on Phase I clinical trials and would like to acquire company with the same or similar characteristics. 

Profile (strategy) of this buyer for Phase I clinical trials CRO   

 The buyer is one of leading European contract research organization and pharmaceutical company which specializes on early stage drug development for the life science industry. 

It is a company that is on the market for more than 35 years and during the last years, is very active in acquisitions. 

The company also performs drug trials for international pharmaceutical companies, biotech and generic manufacturers. 

Other services included in the company’s portfolio: pharmaceutical services, clinical services, non- clinical services and laboratory services.

The company is financially very strong and is capable to bid a very good offer if attractive company appears.

Contact us to get details about this pharma company.

Activities and products of the target company

The buyer is looking for a well-established, mid-size company with a strong financial record and team of experts around. Preferred target is a contract research company which specializes on early stage drug development for the life science industry.  Desired company regularly invents suitable dose of a new drug with the fewest side effects. Than is capable of drug testing on the patients and makes the drug ready to launch on the market. 

Highlights of this buyer for Phase I clinical trials CRO in Europe

  • The buyer is a leading contract research organization and pharmaceutical company which specializes on early stage drug development for the life science industry.
  • Is looking for a financially stable company with a potential and yearly revenue between Has revenue 3-30m
  • Preferred company would perform drug trials for international pharmaceutical companies, biotech and generic manufacturers. 
  • Other services that the buyer is interested are: pharmaceutical services, clinical services, non- clinical services and laboratory services

Information on this buyer for a Phase I clinical trials CRO 

Feel free to contact us for more information regarding this generic drugs company wanted in Europe, or if you know possible interested or suitable parties. For more buyers of pharmaceutical companies please visit the section pharmaceutical companies wanted. For pharmaceutical companies for sale visit the section pharmaceutical companies for sale.



Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.